Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 8, 2026Journal of the American College of CardiologyOpen Access

Inferior Vena Cava Filters to Prevent Pulmonary Embolism

View Full Paper
Ask AI
Bookmark
Share

Key result

IVC filters reduce subsequent PE risk ~50% but increase DVT risk.

  • OR 0.50
  • 95% CI 0.33 to 0.75

Why the study?

Inferior vena cava filters are widely used to prevent pulmonary embolism, but uncertainty persists regarding their efficacy and safety.

Do inferior vena cava filters reduce the risk of pulmonary embolism in patients at risk of PE?

Population

Patients at risk of PE across 11 studies (6 RCTs and 5 prospective observational studies)

Comparison

IVC filters vs no filters

Design

Systematic review and meta-analysis of RCTs and prospective controlled observational studies

Authors

Behnood BikdeliBehnood BikdeliVascular MedicineSCSaurav ChatterjeeInterventional CardiologyNDNihar R. DesaiHeart Failure & Transplant

Discussion

Loading...

Member takes

Key expert perspectives

Captured external expert commentary on this paper, strongest first. Original sources are linked where available.

Behnood BikdeliBehnood BikdeliCardiovascular medicine, Columbia University Medical Center

“The most striking news to come out of the research is how few papers exist. That to me speaks to the need for much more research in this area.”

NewYork-Presbyterian Hospital/Columbia University Medical CenterNews Coverage
SVStavros V. KonstantinidesThrombosis specialist, University Medical Center Mainz

“The most important message [of the current paper] lies... in the quantity and quality of the evidence that the authors were able to retrieve over an impressive time period spanning no less than 43 years.”

University Medical Center MainzNews Coverage

Implication

Supports selective short-term IVC filter use when anticoagulation is contraindicated; confirms PE-DVT trade-off without mortality benefit.

Key Points

  • To evaluate the clinical indications, efficacy, and complication profiles associated with the placement of inferior vena cava filters to prevent pulmonary embolism.
  • Synthesized clinical evidence evaluating mechanical interruption of the inferior vena cava in individuals with or at risk for venous thromboembolism.
  • Assessed device safety profiles, retrieval feasibility, and clinical outcomes relative to standard pharmacological anticoagulation.
  • Inferior vena cava filters provide effective short-term mechanical protection against fatal and nonfatal pulmonary embolism in patients with active proximal deep vein thrombosis who have absolute contraindications to anticoagulation.
  • Prolonged or permanent filter dwell times are linked to elevated risks of recurrent deep vein thrombosis, filter thrombosis, migration, and structural vessel wall perforation.

Study Design

Type

Meta-Analysis

Structured PICO

Do inferior vena cava filters reduce the risk of pulmonary embolism in patients at risk of PE?

P
Population
11 studies (6 RCTs and 5 prospective observational studies) evaluating IVC filters versus none in patients at risk of pulmonary embolism.
I
Intervention
Inferior vena cava (IVC) filters
C
Comparator
No IVC filter
O
Outcome
Subsequent pulmonary embolism (PE), PE-related mortality, all-cause mortality, and subsequent deep vein thrombosis (DVT)hard clinical

Main Result

Odds Ratio: 0.5 (95% CI 0.33–0.75)

IVC filters reduce the risk of subsequent pulmonary embolism but increase the risk of deep vein thrombosis, without affecting overall mortality.

Limitations

  • Very few prospective controlled studies exist
  • Limited quality of evidence
  • Very few prospective controlled studies

Cite This Study

Bikdeli et al. (2017) conducted a meta-analysis in Risk of pulmonary embolism. Inferior vena cava (IVC) filters vs. None was evaluated on Subsequent pulmonary embolism (OR 0.50, 95% CI 0.33 to 0.75). Inferior vena cava filters reduced the risk of subsequent pulmonary embolism (OR 0.50; 95% CI 0.33-0.75) but increased the risk for deep vein thrombosis (OR 1.70; 95% CI 1.17-2.48).

synapsesocial.com/papers/6a9fd2f6581545727ab413d6https://doi.org/10.1016/j.jacc.2017.07.775
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Eight-Year Follow-Up of Patients With Permanent Vena Cava Filters in the Prevention of Pulmonary Embolism2005 · 935 citations
  2. 2Estimated Annual Number of Incident and Recurrent, Non-Fatal and Fatal Venous Thromboembolism (VTE) Events in the US.2005 · 348 citations
  3. 3Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association2017 · 12,803 citations
  4. 4Risks and benefits of prophylactic inferior vena cava filters in patients undergoing bariatric surgery2013 · 56 citations